{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T17:12:40Z","timestamp":1725297160743},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Government Of Equatorial Guinea"},{"name":"Marathon E.G. Production"},{"name":"Noble Energy Equatorial Guinea"},{"name":"Atlantic Methanol Production Company"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Loa loa microfilariae were found on thick blood smears (TBSs) from 8 of 300 (2.7%) residents of Bioko Island, Equatorial Guinea, during a Plasmodium falciparum sporozoite malaria vaccine clinical trial. Only one subject was found to have microfilaraemia on his first exam; parasites were not discovered in the other seven until subsequent TBSs were performed, at times many weeks into the study. All infected individuals were asymptomatic, and were offered treatment with diethylcarbamazine, per national guidelines. L. loa microfilaraemia complicated the enrolment or continued participation of these eight trial subjects, and only one was able to complete all study procedures. If ruling out loiasis is deemed to be important during clinical trials, tests that are more sensitive than TBSs should be performed.<\/jats:p>","DOI":"10.1093\/trstmh\/trac019","type":"journal-article","created":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T20:12:27Z","timestamp":1647115947000},"page":"745-749","source":"Crossref","is-referenced-by-count":1,"title":["The impact of <i>Loa loa<\/i> microfilaraemia on research subject retention during a whole sporozoite malaria vaccine trial in Equatorial Guinea"],"prefix":"10.1093","volume":"116","author":[{"given":"Stephen R","family":"Manock","sequence":"first","affiliation":[{"name":"Sanaria Inc. , Rockville, MD 20850, USA"},{"name":"Department of Family Medicine, John Peter Smith Hospital , Fort Worth, TX 76104, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente Urbano","family":"Nsue","sequence":"additional","affiliation":[{"name":"National Malaria Control Program, Ministry of Health and Social Welfare , Malabo, Equatorial Guinea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ally","family":"Olotu","sequence":"additional","affiliation":[{"name":"Department of Interventions & Clinical Trials, Ifakara Health Institute , Box 74, Bagamoyo, Tanzania"},{"name":"KEMRI Wellcome Trust Research Programme , P.O. Box 230-80108 Kilifi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximillian","family":"Mpina","sequence":"additional","affiliation":[{"name":"Department of Interventions & Clinical Trials, Ifakara Health Institute , Box 74, Bagamoyo, Tanzania"},{"name":"Department of Medical Parasitology and Infection Biology, Clinical Immunology, Swiss Tropical and Public Health Institute , 4002 Basel, Switzerland"},{"name":"University of Basel , Petersplatz 1, 4001 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Nyakarungu","sequence":"additional","affiliation":[{"name":"Department of Interventions & Clinical Trials, Ifakara Health Institute , Box 74, Bagamoyo, Tanzania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Raso","sequence":"additional","affiliation":[{"name":"National Malaria Control Program, Ministry of Health and Social Welfare , Malabo, Equatorial Guinea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Mtoro","sequence":"additional","affiliation":[{"name":"Department of Interventions & Clinical Trials, Ifakara Health Institute , Box 74, Bagamoyo, Tanzania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn Eka","family":"Ondo Mangue","sequence":"additional","affiliation":[{"name":"National Malaria Control Program, Ministry of Health and Social Welfare , Malabo, Equatorial Guinea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beltr\u00e1n Ekua","family":"Ntutumu Pasialo","sequence":"additional","affiliation":[{"name":"National Malaria Control Program, Ministry of Health and Social Welfare , Malabo, Equatorial Guinea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rufino","family":"Nguema","sequence":"additional","affiliation":[{"name":"National Program for Onchocerciasis and Other Filariasis Control, Ministry of Health and Social Welfare , Malabo, Equatorial Guinea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pouria","family":"Riyahi","sequence":"additional","affiliation":[{"name":"Sanaria Inc. , Rockville, MD 20850, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Schindler","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology and Infection Biology, Clinical Immunology, Swiss Tropical and Public Health Institute , 4002 Basel, Switzerland"},{"name":"University of Basel , Petersplatz 1, 4001 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Daubenberger","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology and Infection Biology, Clinical Immunology, Swiss Tropical and Public Health Institute , 4002 Basel, Switzerland"},{"name":"University of Basel , Petersplatz 1, 4001 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L W Preston","family":"Church","sequence":"additional","affiliation":[{"name":"Sanaria Inc. , Rockville, MD 20850, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter F","family":"Billingsley","sequence":"additional","affiliation":[{"name":"Sanaria Inc. , Rockville, MD 20850, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L","family":"Richie","sequence":"additional","affiliation":[{"name":"Sanaria Inc. , Rockville, MD 20850, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Abdulla","sequence":"additional","affiliation":[{"name":"Department of Interventions & Clinical Trials, Ifakara Health Institute , Box 74, Bagamoyo, Tanzania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Sanaria Inc. , Rockville, MD 20850, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"issue":"6","key":"2022080602595186500_bib1","doi-asserted-by":"crossref","first-page":"e1210","DOI":"10.1371\/journal.pntd.0001210","article-title":"The geographic distribution of Loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA)","volume":"5","author":"Zour\u00e9","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"issue":"3","key":"2022080602595186500_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4269\/ajtmh.1985.34.537","article-title":"Loiasis: \u201cCalabar\u201d swellings and involvement of deep organs","volume":"34","author":"Negesse","year":"1985","journal-title":"Am J Trop Med Hyg."},{"issue":"11","key":"2022080602595186500_bib3","doi-asserted-by":"crossref","first-page":"e0006920","DOI":"10.1371\/journal.pntd.0006920","article-title":"Removal of adult subconjunctival Loa loa amongst urban dwellers in Nigeria","volume":"12","author":"Okonkwo","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"issue":"11","key":"2022080602595186500_bib4","doi-asserted-by":"crossref","first-page":"ofz417","DOI":"10.1093\/ofid\/ofz417","article-title":"Atypical clinical manifestations of loiasis and their relevance for endemic populations","volume":"6","author":"Buell","year":"2019","journal-title":"Open Forum Infect Dis."},{"issue":"1","key":"2022080602595186500_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1473-3099(16)30405-4","article-title":"Excess mortality associated with loiasis: a retrospective population-based cohort study","volume":"17","author":"Chesnais","year":"2017","journal-title":"Lancet Infect Dis."},{"issue":"9070","key":"2022080602595186500_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"Gardon","year":"1997","journal-title":"Lancet"},{"key":"2022080602595186500_bib7","author":"World Health Organization","year":"1995","journal-title":"WHO model prescribing information: drugs used in parasitic diseases"},{"issue":"2","key":"2022080602595186500_bib8","first-page":"155","article-title":"Les probl\u00e8mes actuels de la loase [Current problems of loiasis]","volume":"56","author":"Fain","year":"1978","journal-title":"Bull World Health Org."},{"issue":"4","key":"2022080602595186500_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1473-3099(13)70263-9","article-title":"Loa loa-does it deserve to be neglected?","volume":"14","author":"Metzger","year":"2014","journal-title":"Lancet Infect Dis."},{"issue":"1","key":"2022080602595186500_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4269\/ajtmh.20-0435","article-title":"Immunogenicity and protective efficacy of radiation-attenuated and chemo-attenuated PfSPZ vaccines in Equatoguinean adults","volume":"104","author":"Jongo","year":"2021","journal-title":"Am J Trop Med Hyg."},{"issue":"6152","key":"2022080602595186500_bib11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"Seder","year":"2013","journal-title":"Science."},{"issue":"5","key":"2022080602595186500_bib12","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(17)30104-4","article-title":"Safety and efficacy of PfSPZ vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial","volume":"17","author":"Sissoko","year":"2017","journal-title":"Lancet Infect Dis."},{"issue":"6","key":"2022080602595186500_bib13","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.4269\/ajtmh.18-0835","article-title":"Safety and differential antibody and T-cell responses to the Plasmodium falciparum sporozoite malaria vaccine, PfSPZ vaccine, by age in Tanzanian adults, adolescents, children, and infants","volume":"100","author":"Jongo","year":"2019","journal-title":"Am J Trop Med Hyg."},{"issue":"1","key":"2022080602595186500_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4269\/ajtmh.17-0449","article-title":"Advancing global health through development and clinical trials partnerships: a randomized, placebo-controlled, double-blind assessment of safety, tolerability, and immunogenicity of PfSPZ vaccine for malaria in healthy Equatoguinean men","volume":"98","author":"Olotu","year":"2018","journal-title":"Am J Trop Med Hyg."},{"issue":"7642","key":"2022080602595186500_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature21060","article-title":"Sterile protection against human malaria by chemoattenuated PfSPZ vaccine","volume":"542","author":"Mordm\u00fcller","year":"2017","journal-title":"Nature."},{"issue":"8","key":"2022080602595186500_bib16","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1371\/journal.pntd.0001299","article-title":"Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia","volume":"5","author":"Fink","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"issue":"1","key":"2022080602595186500_bib17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4269\/ajtmh.18-0163","article-title":"In southern Nigeria Loa loa blood microfilaria density is very low even in areas with high prevalence of loiasis: results of a survey using the new LoaScope technology","volume":"99","author":"Emukah","year":"2018","journal-title":"Am J Trop Med Hyg."},{"issue":"7","key":"2022080602595186500_bib18","doi-asserted-by":"crossref","first-page":"e0004829","DOI":"10.1371\/journal.pntd.0004829","article-title":"Evidence for suppression of onchocerciasis transmission in Bioko Island, Equatorial Guinea","volume":"10","author":"Moya","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"issue":"4","key":"2022080602595186500_bib19","doi-asserted-by":"crossref","first-page":"ofz019","DOI":"10.1093\/ofid\/ofz019","article-title":"Effect of a single standard dose (150\u2013200 \u03bcg\/kg) of Ivermectin on Loa loa microfilaremia: systematic review and meta-analysis","volume":"6","author":"Pion","year":"2019","journal-title":"Open Forum Infect Dis."},{"issue":"4","key":"2022080602595186500_bib20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0035-9203(98)91091-4","article-title":"Impact of repeated large scale ivermectin treatments on the transmission of Loa loa","volume":"92","author":"Chippaux","year":"1998","journal-title":"Trans R Soc Trop Med Hyg."},{"issue":"4","key":"2022080602595186500_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S0022149X15000607","article-title":"The relationship between microfilaraemic and amicrofilaraemic loiasis involving co-infection with Mansonella perstans and clinical symptoms in an exposed population from Gabon","volume":"90","author":"Bouyou Akotet","year":"2016","journal-title":"J Helminthol."},{"issue":"10","key":"2022080602595186500_bib22","doi-asserted-by":"crossref","first-page":"e00706","DOI":"10.1128\/JCM.00706-19","article-title":"Diagnostic identification and differentiation of microfilariae","volume":"57","author":"Mathison","year":"2019","journal-title":"J Clin Microbiol."},{"key":"2022080602595186500_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.actatropica.2017.12.030","article-title":"Geographical distribution and species identification of human filariasis and onchocerciasis in Bioko Island, Equatorial Guinea","volume":"180","author":"Ta","year":"2018","journal-title":"Acta Trop."},{"issue":"1","key":"2022080602595186500_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/cid\/ciu723","article-title":"Eosinophil-associated processes underlie differences in clinical presentation of loiasis between temporary residents and those indigenous to Loa-endemic areas","volume":"60","author":"Herrick","year":"2015","journal-title":"Clin Infect Dis."},{"issue":"3","key":"2022080602595186500_bib25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4269\/ajtmh.15-0214","article-title":"Clinical features of imported loiasis: a case series from the Hospital for Tropical Diseases, London","volume":"93","author":"Saito","year":"2015","journal-title":"Am J Trop Med Hyg."},{"issue":"11","key":"2022080602595186500_bib26","doi-asserted-by":"crossref","first-page":"e0006917","DOI":"10.1371\/journal.pntd.0006917","article-title":"Comparison of different drug regimens for the treatment of loiasis-A TropNet retrospective study","volume":"12","author":"Gobbi","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"issue":"1","key":"2022080602595186500_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40249-020-0627-4","article-title":"Loiasis in sub-Saharan migrants living in Spain with emphasis of cases from Equatorial Guinea","volume":"9","author":"Puente","year":"2020","journal-title":"Infect Dis Poverty."},{"issue":"8","key":"2022080602595186500_bib28","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/cid\/cix016","article-title":"Posttreatment reactions after single-dose diethylcarbamazine or ivermectin in subjects with Loa loa infection","volume":"64","author":"Herrick","year":"2017","journal-title":"Clin Infect Dis."},{"key":"2022080602595186500_bib29","doi-asserted-by":"crossref","first-page":"F1000 Faculty Rev-1685","DOI":"10.12688\/f1000research.15596.1","article-title":"Helminth parasites and immune regulation","volume":"7","author":"Gazzinelli-Guimaraes","year":"2018","journal-title":"F1000Res."},{"key":"2022080602595186500_bib30","first-page":"43","article-title":"Loa loa infection detection using biomarkers: current perspectives","author":"Akue","year":"2018","journal-title":"Res Rep Trop Med."},{"key":"2022080602595186500_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-7020-3935-5.00105-1","article-title":"Loiasis and Mansonella infections","volume-title":"Tropical infectious diseases: principles, pathogens and practice","author":"Klion","year":"2011","edition":"3rd ed."}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/116\/8\/745\/45278162\/trac019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/116\/8\/745\/45278162\/trac019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T03:00:32Z","timestamp":1659754832000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/116\/8\/745\/6565268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,4,8]]},"published-print":{"date-parts":[[2022,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trac019","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8]]},"published":{"date-parts":[[2022,4,8]]}}}